Strain Name: |
MRL.129P2(B6)-Fastm1Osa/J |
|---|---|
Stock Number: |
003234 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Former Name |
MRL.129P2(B6)-Tnfrsf6tm1Osa/J (Changed: 26-JAN-05
) |
| Genes & Alleles | Fas; Fastm1Osa; |
Type JAX® GEMM® Strain - Congenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Targeted Mutation Species laboratory mouse Background Strain MRL/MpJ Donor Strain B6,129P-Tnfrsf6tm1Osa (129P2 derived E14TG2a ES cell line) Donating Investigator Shigekazu Nagata, Osaka University Medical School, B-3 Generation F?+4N1F1pN1 Strain Description
Mice homozygous for the Tnfrsf6tm1Osa targeted mutation mice show hyperplasia in the liver in an age-dependent manner. Hepatocytes contain enlarged nuclei characteristic of senescent cells. Lymphadenopathy and splenomegaly in FAS deficient mice are evident at 8 weeks of age. The lymphnodes and spleen become progressively larger, becoming about 10 and 40 times larger than those of wildtype or heterozygotes at 16 weeks of age, respectively.Strain Development
The targeting vector was constructed by replacing exon 9 of the Fas gene with the neo and beta-galactosidase genes. E14-1 ES cells from 129/Ola mice were disrupted by homologous recombination and injected into blastocysts isolated from C57BL/6 mice.
Related Disease (OMIM) Terms |
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Fastm1Osa | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Osaka University Medical School | ||
| Common Name(s) | Fas-; Tnfrsf6tm1Osa; | ||
| Mutation Made By | Shigekazu Nagata, Osaka University Medical School, B-3 | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14.1 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Fas, Fas (TNF receptor superfamily member 6) | ||
| Chromosome | 19 | ||
| Gene Common Name(s) | AI196731; ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; Fas antigen; TNFR6; TNFRSF6; Tnfrsf6; expressed sequence AI196731; lpr; lymphoproliferation; tumor necrosis factor receptor superfamily, member 6; | ||
| Molecular Note | A BetaGal-neo cassette was used to delete a portion of exon 9, which codes for the cytoplasmic domain essential for Fas-mediated apoptosis. Northern blot analysis revealed the expression of a truncated mRNA, representing transcripts from exons 1 though 8 in the thymus, liver, and heart. Immunoprecipitation analysis showed an absence of the wild-type protein as well as a faint presence of what the authors speculated to be a non-functional Tnfrsf6-BetaGal fusion protein. [MGI Ref ID J:64296] | ||
| MRL/MpJ (Stock # 000485) may be used as controls. | ||
| Considerations for Choosing Controls | ||
Fastm1Osa
Strains carrying Fastm1Osa allele
003233 B6.129P2-Fastm1Osa/J View Strains carrying Fastm1Osa (1 strain)
Strains carrying other alleles of Fas
000482 B6.MRL-Faslpr/J 000480 C3.MRL-Faslpr/J 007895 C57BL/6-Fastm1Cgn/J 001876 CBA/KlJms-Faslpr-cg/J 002455 MRL-Faslpr.129P2(B6)-B2mtm1Unc 002983 MRL.CBAJms-Faslpr-cg/J 003896 MRL/MpJ Faslpr-Foxq1sa-J/J 006825 MRL/MpJ-Faslpr/2J 000485 MRL/MpJ-Faslpr/J 004519 NOD.MRL(C3)-Faslpr/DoiJ 004922 NOD.MRL-Faslpr/Dvs View Strains carrying other alleles of Fas (11 strains)
Congenic Nomenclature
Fastm1Osa related
Apoptosis Research
Death Receptors
Cancer Research
Genes Regulating Growth and Proliferation
Hematological Research
Immunological Defects
Immunology and Inflammation Research
Autoimmunity
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Internal/Organ Research
Spleen Defects
Selected Reference(s)
Additional ReferencesAdachi M; Suematsu S; Kondo T; Ogasawara J; Tanaka T; Yoshida N; Nagata S. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11(3):294-300. [PubMed: 7581453] [MGI Ref ID J:64296]
| Strain Name: | MRL.129P2(B6)-Fastm1Osa/J |
| Stock Number: | 003234 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below |
| Control Information | View Control Information in Strain Details. |
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form